Circulation Research Compendium on Atherothrombosis Drugs

The editors of Circulation Research are pleased to announce a new Compendium on Atherothrombosis Drugs, edited by Sergio Fazio & Jeffrey I. Weitz. This Compendium is free to read throughout February.

Each Compendium is designed as a thematic collection of comprehensive review articles covering a specific cardiovascular disease, pathological condition, or field in its entirety, discussing the major issues, how these issues are being addressed in the laboratory and in the clinic, which important questions remain unanswered, and which pressing issues need urgent attention. We view Compendia as a one-stop shop for basic, translational, and clinical investigators who wish to gather a comprehensive assessment of a topic. Accordingly, we hope that Compendia will provide a valuable resource not only to experts and investigators in the field, but also to nontraditional readers of the journal, such as physicians, cardiology fellows, residents, and medical students.

Compendium on Atherothrombosis Drugs

• Overview of Therapeutic Approaches for Cholesterol Lowering and Attenuation of Thrombosis for Prevention of Atherothrombosis
  Jeffrey I. Weitz, Sergio Fazio
  
  
• Cholesterol-Lowering Agents: Statins—For Everyone?
  Savvas Hadjiphilippou, Kausik K. Ray
  
  
• Cholesterol-Lowering Agents: PCSK9 Inhibitors Today and Tomorrow
  Robert S. Rosenson, Robert A. Hegele, Wolfgang Koenig
  
  
• Lipid-Lowering Agents: Targets Beyond PCSK9
  Robert A. Hegele, Sotirios Tsimikas
  
  
• Potential Causality and Emerging Medical Therapies for Lipoprotein(a) and Its Associated Oxidized Phospholipids in Calcific Aortic Valve Stenosis
  Sotirios Tsimikas
  
  
• Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease: Lessons From the COMPASS Trial
  Michiel Coppens, Jeffrey I. Weitz, John W.A. Eikelboom
  
  
• Antithrombotic Agents: New Directions in Antithrombotic Therapy
  Noel C. Chan, Jeffrey I. Weitz
  
  
• Anticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis
  Paul M Ridker